APA (7th ed.) Citation

Paisdzior, S. (2019). In vitro validation of peptide-T3 conjugates as a treatment option for MCT8-deficiency via a "Trojan Horse"-like mechanism. https://doi.org/10.14279/depositonce-8181

Chicago Style (17th ed.) Citation

Paisdzior, Sarah. In Vitro Validation of Peptide-T3 Conjugates as a Treatment Option for MCT8-deficiency via a "Trojan Horse"-like Mechanism. Berlin, 2019. https://doi.org/10.14279/depositonce-8181.

MLA (9th ed.) Citation

Paisdzior, Sarah. In Vitro Validation of Peptide-T3 Conjugates as a Treatment Option for MCT8-deficiency via a "Trojan Horse"-like Mechanism. 2019. https://doi.org/10.14279/depositonce-8181.